Committee

Full Name	Position	Organization	Term Start	Term End
Keith Wonnacott, PhD	Chair	Lexeo Therapeutics	6/1/2021	5/31/2023
Angela N. Johnson, PhD, MSE	Member	Sigilon	6/1/2021	5/31/2024
Jan E. Thirkettle	Member	Platform Strategy Consulting Ltd	6/1/2020	5/31/2023
Aron Stein	Member	Intellia Therapeutics	6/1/2022	5/31/2025
Michael Havert, PhD	Member		6/1/2019	5/31/2025
Nimi Chhina, JD, PhD	Member	BioMarin Pharmaceutical Inc.	6/1/2022	5/31/2025
Kit L. Shaw, PhD	Member	Dana-Farber Cancer Institute	6/1/2019	5/31/2025
Timothy K. MacLachlan, PhD	Member	Novartis	6/1/2021	5/31/2024
Robert G. Pietrusko	Member	Voyager Therapeutics, Inc.	6/1/2019	5/31/2026
Sandhya Sanduja, Lead Biologist	Member	US Food and Drug Administration	6/1/2019	5/31/2025
Daniela Drago, PhD	Member	Aurion Biotech	6/1/2020	5/31/2023
Megan Zoschg Canniere, PharmD	Member	Spark Therapeutics	6/1/2020	5/31/2023
Nancy Boman, PhD, MD	Member	Encoded Therapeutics	6/1/2022	5/31/2025
Kristin Van Goor, PhD	Member	Vertex	6/1/2022	5/31/2025
Natalia Shunmugan	Member	Ultragenyx Pharmaceutical Inc.	6/1/2022	5/31/2025
Rachel Ruckdeschel Smith	Member	StrideBio, Inc	6/1/2022	5/31/2025
Caitlin McCombs	Staff Liaison	ASGCT	12/1/2021	5/31/2045
Christina Mayer	Staff Liaison	American Society of Gene & Cell Therapy	12/1/2021	5/31/2045